Skip to main content
OpenTrials

Clinical trial condition

Glomerulosclerosis, Focal Segmental

Explore clinical trials studying Glomerulosclerosis, Focal Segmental. Study availability and eligibility vary by location and protocol.

80 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Glomerulosclerosis, Focal Segmental trial results

Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

NCT07220083

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +7 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • Apogee Clinical Research Huntsville, Alabama, United States
  • Southwest Kidney Institute Surprise, Arizona, United States
  • West Coast Kidney Institute Fremont, California, United States
View all 296 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +10 more
Locations
  • Investigational Site Number : 8400007 Birmingham, Alabama, United States
  • Investigational Site Number : 8400015 Orange, California, United States
  • Investigational Site Number : 8400012 San Francisco, California, United States
  • Investigational Site Number : 8400025 Tampa, Florida, United States
View all 71 locations
View Trial Details
Recruiting

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

NCT07268638

Conditions
Chronic Disease, Disease Attributes, Female Urogenital Diseases, +17 more
Locations
  • Investigator Site #2 Chula Vista, California, United States
  • Investigator Site #14 Los Angeles, California, United States
  • Investigator Site #12 San Dimas, California, United States
  • Investigator Site #13 Arvada, Colorado, United States
View all 23 locations
View Trial Details
Recruiting

NEPTUNE Match Study

NCT04571658

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +29 more
Locations
  • Emory University Hospital - Children's Hospital of Atlanta Atlanta, Georgia, United States
  • John H. Stroger, Jr., Hospital of Cook County Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Recruiting

Nephrotic Syndrome Study Network

NCT01209000

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Southern California-Children's Hospital Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California San Francisco Benioff Children's Hospitals San Francisco, California, United States
  • Lundquist Biomedical Research Institute at Harbor UCLA Medical Center Torrance, California, United States
View all 44 locations
View Trial Details
Recruiting

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

NCT05003986

Conditions
Alport Syndrome, Autoimmune Diseases, Blood Coagulation Disorders, +42 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Nemours Children's Hospital Wilmington, Delaware, United States
  • University of Miami, Leonard M. Miller School of Medicine Miami, Florida, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 47 locations
View Trial Details

Related conditions